Drugs / CMS-D008
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07518589 | Apr 2026 → Nov 2027 expected | — | Shenzhen Kangzhe Biotechnology Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CMS-D008 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07518589 ↗ |
| Route | Subcutaneous | “single and multiple subcutaneous injections of CMS-D008 injection” NCT07518589 ↗ |